Keyword Connections

Medicinal Chemistry

Journals

6

1 angewandte chemie (international ed in english)

2 European journal of medicinal chemistry

3 Nature communications

4 Molecules (Basel, Switzerland)

5 turkish journal of chemistry

6 central nervous system agents in medicinal chemistry

Research Groups

0

No Research Group Connected

Bibliographies

42

1 Bisbenzoxazole derivatives had an antiinflammatory effect on in vitro stimulated macrophages

2 Geometric E→Z Isomerisation of Vinyl Silanes by Selective Energy Transfer Catalysis: Stereodivergent Synthesis of Triarylethylenes via a Formal Anti-Metallometallation.

3 Polarization nano-tomography of tightly focused light landscapes by self-assembled monolayers.

4 Diterpenoid lead stevioside and its hydrolysis products steviol and isosteviol: Biological activity and structural modification.

5 Continuous Flow Photochemistry for the Preparation of Bioactive Molecules.

6 applications of organocatalysed visible-light photoredox reactions for medicinal chemistry

7 current and potential applications of bismuth-based drugs

8 transfer and multi-task learning in qsar modeling: advances and challenges

9 tropical biodiversity: has it been a potential source of secondary metabolites useful for medicinal chemistry?

10 α-C(sp3)-H Arylation of Cyclic Carbonyl Compounds

11 Antiviral agents active against influenza A viruses

12 Corrigendum: Synthesis and in vitro antioxidant activity of new pyrimidin/benzothiazol substituted piperazinyl flavones(Medicinal Chemistry (2018) 10:19 (2293–2308) DOI: 10.4155/fmc-2018-0206)

13 Corrigendum to“An insight into the medicinal perspective of synthetic analogs of indole: A review” (European Journal of Medicinal Chemistry (2019) 180 (562–612), (S0223523419306403), (10.1016/j.ejmech.2019.07.019))

14 1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview.

15 Corrigendum to ‘Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA’ (Bioorganic & Medicinal Chemistry Letters (2019) 29(10) (1246–1255), (S0960894X19300617), (10.1016/j.bmcl.2019.01.040))

16 Pyrazolone structural motif in medicinal chemistry: Retrospect and prospect.

17 Acetylene Group, Friend or Foe in Medicinal Chemistry.

18 Corrigendum to “Design, synthesis, and biological evaluation of a new class of histone acetyltransferase p300 inhibitors” (European Journal of Medicinal Chemistry (2019) 180 (171–190), (S0223523419306488), (10.1016/j.ejmech.2019.07.026))

19 Corrigendum to “Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer” (European Journal of Medicinal Chemistry (2019) 163 (787–803), (S0223523418310614), (10.1016/j.ejmech.2018.12.024))

20 Erratum: Novel Ligustrazine-Based Analogs of Piperlongumine Potently Suppress Proliferation and Metastasis of Colorectal Cancer Cells in Vitro and in Vivo (Journal of Medicinal Chemistry (2018) 61:5 (1821-1832) DOI: 10.1021/acs.jmedchem.7b01096)

21 Corrigendum to ‘Exploration of novel pyrrolo[2,1-f][1,2,4]triazine derivatives with improved anticancer efficacy as dual inhibitors of c-Met/VEGFR-2’ [European journal of medicinal chemistry 158 (2018) 814–831](S0223523418308225)(10.1016/j.ejmech.2018.09.050)

22 Erratum: Ligands and Receptors with Broad Binding Capabilities Have Common Structural Characteristics: An Antibiotic Design Perspective (Journal of Medicinal Chemistry (2019) 62:21 (9357-9374) DOI: 10.1021/acs.jmedchem.9b00220)

23 Erratum: Discovery and Optimization of 4,5-Diarylisoxazoles as Potent Dual Inhibitors of Pyruvate Dehydrogenase Kinase and Heat Shock Protein 90 (Journal of Medicinal Chemistry (2014) 57:23 (9832-9843) DOI: 10.1021/jm5010144)

24 Correction to: Structure-based in silico screening identifies a potent ebolavirus inhibitor from a traditional chinese medicine library (Journal of Medicinal Chemistry (2019) 62:6 (2928-2937) DOI: 10.1021/acs.jmedchem.8b01328)

25 Correction: Triple Reuptake Inhibitors as Potential Therapeutics for Depression and Other Disorders: Design Paradigm and Developmental Challenges" (Journal of Medicinal Chemistry (2018) 61:6 (2133-2165) DOI: 10.1021/acs.jmedchem.6b01827)

26 Corrigendum to “Synthesis and preliminary antiproliferative activity of new pteridin-7(8H)-one derivatives” (European Journal of Medicinal Chemistry (2018) 143 (1396–1405), (S0223523417308371), (10.1016/j.ejmech.2017.10.037))

27 Correction: Discovery of 3-Oxabicyclo[4.1.0]heptane, a Non-nitrogen Containing Morpholine Isostere, and Its Application in Novel Inhibitors of the PI3K-AKT-mTOR Pathway (Journal of Medicinal Chemistry (2019) 62: 15 (6972−6984) DOI: 10.1021/acs.jmedchem.9b00348)

28 Expression of Concern: Identification of Eukaryotic Translation Elongation Factor 1-α 1 Gamendazole-Binding Site for Binding of 3-Hydroxy-4(1 H)-quinolinones as Novel Ligands with Anticancer Activity (Journal of Medicinal Chemistry (2018) 61: 7 (3027−3036) DOI: 10.1021/acs.jmedchem.8b00078)

29 Correction: Discovery of Entrectinib: A New 3-Aminoindazole as a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor (Journal of Medicinal Chemistry (2016) 59: 7 (3392-3408) DOI: 10.1021/acs.jmedchem.6b00064)

30 Corrigendum to “Photocytotoxic oxovanadium(IV) complexes of ferrocenyl-terpyridine and acetylacetonate derivatives” (European Journal of Medicinal Chemistry (2015) 92 (332–341), (S0223523415000148), (10.1016/j.ejmech.2015.01.003))

31 Erratum: Intrinsic activity of oxygen evolution catalysts probed at single CoFe<inf>2</inf>O<inf>4</inf> nanoparticles (Journal of Medicinal Chemistry (2019) 141:23 (9197-9201) DOI: 10.1021/jacs.9b04516)

32 Erratum: Tuning the reactivity of difluoromethyl sulfoximines from electrophilic to nucleophilic: Stereoselective nucleophilic difluoromethylation of aryl ketones (Journal of Medicinal Chemistry (2012) 134:41 (16999-17002) DOI: 10.1021/ja308419a)

33 Corrigendum to <‘Synthesis and biological evaluation of 2,6-disubstituted-9H-purine, 2,4-disubstitued-thieno[3,2-d]pyrimidine and -7H-pyrrolo[2,3-d] pyrimidine analogues as novel CHK1 inhibitors’ [Eur. J. Med. Chem. 151 (2018) 836–848] (European Journal of Medicinal Chemistry (2018) 151 (836–848), (S0223523418303192), (10.1016/j.ejmech.2018.03.075))

34 Correction to: Structural basis for potency and promiscuity in poly(ADP-ribose) polymerase (PARP) and tankyrase inhibitors (Journal of Medicinal Chemistry (2017) 60: 4 (1262-1271) DOI: 10.1021/acs.jmedchem.6b00990)

35 Correction to: Structure-Based Design of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors Based on Paroxetine (Journal of Medicinal Chemistry (2017) 60:7 (3052-3069) DOI: 10.1021/acs.jmedchem.7b00112)

36 Corrigendum to “From hit to lead: Structure-based discovery of naphthalene-1-sulfonamide derivatives as potent and selective inhibitors of fatty acid binding protein 4” (European Journal of Medicinal Chemistry (2018) 154 (44–59), (S0223523418304112) (10.1016/j.ejmech.2018.05.007))

37 Correction: Discovery of a Natural-Product-Derived Preclinical Candidate for Once-Weekly Treatment of Type 2 Diabetes (Journal of Medicinal Chemistry (2019) 62:5 (2348-2361) DOI: 10.1021/acs.jmedchem.8b01491)

38 Correction to: Synthesis of <sup>11</sup>C-Labeled RXR Partial Agonist 1-[(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)amino]benzotriazole-5-carboxylic Acid (CBt-PMN) by Direct [<sup>11</sup>C]Carbon Dioxide Fixation via Organolithiation of Trialkyltin Precursor and PET Imaging Thereof (Journal of Medicinal Chemistry (2017) 60:16 (7139-7145) DOI: 10.1021/acs.jmedchem.7b00817)

39 Correction to: Remarkable Brain Penetration of Cyclopentadienyl M(CO)<inf>3</inf><sup>+</sup> (M = <sup>99m</sup>Tc, Re) Derivatives of Benzothiazole and Benzimidazole Paves the Way for Their Application as Diagnostic, with Single-Photon-Emission Computed Tomography (SPECT), and Therapeutic Agents for Alzheimer's Disease (Journal of Medicinal Chemistry (2019) 62:5 (2638-2650) DOI: 10.1021/acs.jmedchem.8b01949)

40 A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery

41 2<sup>nd</sup> anglo-croatian medicinal symposium on macrocycles medicinal chemistry and beyond-the-rule-of-five

42 a química medicinal de n-acilidrazonas: novos compostos-protótipos de fármacos analgésicos, antiinflamatórios e anti-trombóticos medicinal chemistry of n-acylhydrazones: novel lead-compounds of analgesic, antiinflammatory and antithrombotic drugs